Company intelligence / Profile preview
Shennon Biotechnologies
San Francisco, California, United Statesshennonbio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Shennon Biotechnologies has developed a proprietary single-cell platform that enables rapid, high-throughput functional profiling of millions of immune cells to identify rare antigen-specific T or B cells. This technology aims to accelerate the development of more effective immunotherapies against solid tumors by finding novel targets that are difficult to discover using conventional methods. The company has demonstrated proof-of-concept by identifying rare functionally activated T cells from patient samples in collaboration with multiple clinical centers.
- Therapeutic areas
- Oncology
- Modalities
- T cell therapies (TCR-T)T cell engagersAntibody discovery (potentially)Cell therapy platforms
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with multiple clinical centers for patient sample studiespharma partnerships mentioned but not named specifically.
Beyond the preview
Go deeper on Shennon Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shennon Biotechnologies.